Showing results (101-110 of 140) with videos related to
Sort By:
Pageof 14
Tumori|August 1, 1981
Prognostic significance of the growth rate of breast cancer: preliminary evaluation on the follow-up of 196 breast cancersE Galante, A Guzzon, G Gallus, et al.Actas Urologicas Espanolas|July 18, 2001
[Signet ring-cell adenocarcinoma in colocystoplasty]A Bono Ariño, J I Sanz Vélez, M A Esclarin Duny, et al.Oncology Reports|May 21, 2011
Phase-ii trial of oral doxifluridine plus oral levo-leucovorin in unresectable hepatocellular-carcinomaM Colleoni, M Dibartolomeo, E Bajetta, et al.Archivos Espanoles De Urologia|February 14, 1998
[The neurological status in patients with erectile dysfunction: somatosensory evoked potentials and the bulbocavernosus reflex]A Bono Ariño, A Piñero Fernández, L Rodríguez Vela, et al.Actas Urologicas Espanolas|February 21, 1998
[Positive margins. Surgical techniques and progression after radical prostatectomy]M J Gil Sanz, P Elena, A Borque Fernando, et al.Tumori|February 28, 1994
Ovarian function suppression with the gonadotrophin-releasing hormone (GnRH) analogue goserelin in premenopausal advanced breast cancerE Bajetta, L Celio, N Zilembo, et al.Breast Cancer Research and Treatment|June 1, 1995
Biological and clinical evaluation of lanreotide (BIM 23014), a somatostatin analogue, in the treatment of advanced breast cancer. A pilot study by the I.T.M.O. Group. Italian Trials in Medical OncologyA Di Leo, L Ferrari, E Bajetta, et al.Actas Urologicas Espanolas|June 1, 1997
[Cervico-urethro-suspension by the Raz's technique in the treatment of stress urinary incontinence in women]A Bono Ariño, C Rioja Sanz, A Borque Fernando, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Which therapy for unexpected phyllode tumour of the breast?S Zurrida, C Bartoli, V Galimberti, et al.Journal of Cancer Research and Clinical Oncology|January 1, 1995
Formestane: an effective first-line endocrine treatment for advanced breast cancerN Zilembo, E Bajetta, C Noberasco, et al.Pageof 14